Influence of blood glucose fluctuations on chemotherapy efficacy and safety in type 2 diabetes mellitus patients complicated with lung carcinoma

Table 2 Comparison of tumor markers after chemotherapy

	CA19-9 (U/mL)	CA125 (U/mL)	CEA (mg/L)	NSE (mg/L)	CYFRA21-1 (mg/L)
Control group (n = 30)	64.26 ± 5.20	65.27 ± 6.60	12.12 ± 2.11	15.97 ± 1.34	4.98 ± 0.82
Observation group (n = 30)	75.00 ± 9.48	83.72 ± 6.06	17.83 ± 2.28	19.86 ± 1.42	7.54 ± 0.96
t value	5.444	11.28	10.08	10.88	11.11
P value	< 0.0001	< 0.0001	< 0.0001	< 0.0001	< 0.0001

CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; NSE: Neuron-specific enolase; CYFRA21-1: Cytokeratin 19.